MOSCOW, 15 Sep. The Russian Sputnik V coronavirus vaccine has demonstrated 97.2% efficacy against coronavirus and a high safety profile during vaccination in Belarus, the Russian Direct Investment Fund (RDIF) reported. the Ministry of Health of the Republic of Belarus on the use of the Russian vaccine against the Sputnik V coronavirus during the vaccination campaign in the country, which confirm the high safety and efficacy of the drug. The effectiveness of the Russian vaccine against coronavirus in Belarus was 97.2%, «the report says.
The EMA told about the timing of the registration of vaccines against COVID-19 in the EU «In Belarus: there are no cases of serious adverse events after vaccination; there are no deaths associated with vaccination,» the RDIF added. Belarus became the first foreign state to register the Sputnik V vaccine and began to use it for mass vaccination of the population. In addition, RDIF and partners carried out a technological transfer to localize vaccine production by the Belarusian enterprise Belmedpreparaty. In April of this year, Sputnik V, produced in Belarus, received approval from the country's Ministry of Health. Sputnik V was approved in 70 countries with a total population of 4 billion people, which is more than 50% of the world's population. Sputnik V ranks second in the world in terms of the number of approvals received by government regulators. The effectiveness of the vaccine was 97.6% based on the analysis of data on 3.8 million vaccinated Russians, which is higher than the data previously published by the medical journal The Lancet (91.6%), the Russian Direct Investment Fund (RDIF) and the Gamaleya Research Center reported earlier.
